Date published: 2025-12-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC391746 Activators

LOC391746 Activators are a collection of chemical compounds that indirectly promote the functional activity of LOC391746 through specific signaling pathways and cellular processes. Forskolin, by increasing intracellular cAMP, leads to PKA activation which can phosphorylate substrates that may interact with LOC391746, potentially enhancing its activity. Ionomycin, acting as a calcium ionophore, raises intracellular Ca2+ levels, activating signaling pathways that could modify LOC391746 activity through allosteric changes or post-translational modifications. PMA stimulates PKC, which might phosphorylate regulatory proteins that affect LOC391746's function, while EGCG inhibits kinases that otherwise compete with or negatively regulate LOC391746, thus possibly increasing its activity. Sphingosine-1-phosphate engages its receptors to initiate signaling cascades that indirectly influence LOC391746 activity, and LY294002, by inhibiting PI3K, shifts cellular responses toward pathways that could potentiate LOC391746 function.

Additional compounds like U0126 and SB203580, which inhibit MEK and p38 MAPK respectively, may indirectly enhance LOC391746's activity by reducing the negative feedback on pathways that LOC391746 is involved in. Similarly, the calcium ionophores A23187 and Thapsigarginincrease cytosolic calcium levels, which could stimulate calcium-dependent signaling pathways to modulate LOC391746's activity. Genistein, as a tyrosine kinase inhibitor, might allow an increase in activity of LOC391746 by reducing competitive signaling interactions. Finally, Staurosporine, despite its broad-spectrum inhibitory effects on kinases, may lead to the selective enhancement of pathways that regulate LOC391746, by lifting the inhibition on specific kinases that suppress LOC391746's signaling processes. Collectively, these LOC391746 Activators, through their targeted effects on cellular signaling, facilitate the functional enhancement of LOC391746 activities without affecting its expression levels directly.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin is a calcium ionophore that elevates intracellular Ca2+ levels. This can activate calcium-dependent signaling pathways, which may upregulate or alter the activity of LOC391746 through post-translational modifications or allosteric effects.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA is a PKC activator that can modulate signal transduction pathways. PKC activation may lead to phosphorylation events that influence the functional state of LOC391746, enhancing its activity.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG is known to inhibit certain kinases, which could reduce negative regulation on signaling pathways involving LOC391746, leading to increased activity of LOC391746 due to reduced competition.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

Sphingosine-1-phosphate acts on its receptors to activate intracellular signaling cascades, potentially altering the activity of LOC391746 through downstream effects on proteins that regulate LOC391746's function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor that can shift the balance of intracellular signaling towards pathways that increase the activity of LOC391746, due to reduced competition from PI3K-dependent pathways.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 is a MEK inhibitor that may upregulate LOC391746 activity by reducing negative feedback loops within the MAPK pathway, thereby indirectly enhancing the signaling events LOC391746 is involved in.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAPK inhibitor that could enhance LOC391746's activity by altering the signaling dynamics and reducing competition from p38 MAPK-regulated pathways.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A23187 is a calcium ionophore that increases intracellular calcium levels, which can stimulate calcium-dependent signaling pathways that may modulate the activity of LOC391746.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) and leads to increased cytosolic calcium levels, potentially affecting LOC391746 activity through calcium signaling pathways.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein is a tyrosine kinase inhibitor that may reduce competitive signaling and indirectly enhance the pathways that regulate or interact with LOC391746, promoting its activity.